Sun Pharmaceutical Industries Limited (BOM:524715)
India
· Delayed Price · Currency is INR | Market Cap | 4.16T |
| Revenue (ttm) | 516.03B |
| Net Income (ttm) | 114.34B |
| Shares Out | n/a |
| EPS (ttm) | 47.71 |
| PE Ratio | 36.34 |
| Forward PE | 32.18 |
| Dividend | 15.50 (0.89%) |
| Ex-Dividend Date | Feb 6, 2025 |
| Volume | 51,791 |
| Average Volume | 75,779 |
| Open | 1,714.30 |
| Previous Close | 1,707.35 |
| Day's Range | 1,711.80 - 1,759.00 |
| 52-Week Range | 1,376.75 - 1,960.20 |
| Beta | n/a |
| RSI | 47.92 |
| Earnings Date | May 22, 2025 |
About BOM:524715
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and othe... [Read more]
Financial Performance
In 2023, BOM:524715's revenue was 484.97 billion, an increase of 10.51% compared to the previous year's 438.86 billion. Earnings were 95.76 billion, an increase of 13.01%.
Financial StatementsNews
Q4 FY25 results today: ITC, Sun Pharma, Grasim, Emcure, ConCor, Honasa, Deepak Fertilisers, among 50+ companies to declare earnings
A busy day lies ahead for investors on Wednesday, May 22, as more than 50 companies across sectors are scheduled to announce their financial results for the quarter ended March 31, 2025 (Q4 FY25). The...
Stocks to watch on May 22: IndiGo, Nalco, Mankind Pharma, Colgate in focus after Q4 results; ITC, Sun Pharma, Grasim to report today
A host of major Indian companies are in focus today, May 22, as investors react to fresh earnings reports and await key results. Companies across diverse sectors—from aviation and infrastructure to ph...
Stocks to watch on news today: Dr Reddy’s, Sun Pharma, BEL, JSW Steel, NBCC, Max Healthcare, PNC Infra in focus
Several companies are likely to remain in focus today owing to key regulatory updates, project wins, acquisitions, and strategic corporate announcements. Dr Reddy’s Laboratories received two observati...
Stocks to watch today on May 19: Hyundai, Waaree, IRCTC, IndusInd, Sun Pharma, NBCC, BEL in focus
A host of developments across corporate earnings, regulatory updates, and strategic announcements are likely to influence stock market activity today, May 19. Hyundai Motor India has recommended a fin...
Nifty 50 top losers this week (May 17): IndusInd Bank, Bharti Airtel and Sun Pharmaceutical
India’s benchmark stock indices—Nifty 50 and Sensex—posted a strong weekly performance, climbing sharply as investor sentiment improved. Both indices surged over 4%, marking one of the best weekly gai...
Nifty 50 top gainers today, May 13: Bharat Electronics, Jio Financial Services, Hero MotoCorp, Sun Pharmaceutical and more
The Indian stock market witnessed a sharp decline, with benchmark indices closing significantly lower. The Nifty 50 settled at 24,578.35, down 346.35 points or 1.39%, while the Sensex plunged 1,281.68...
Citi, Nomura cautious on pharma after US price control move; Sun Pharma seen at risk
Global brokerages Citi and Nomura have flagged potential risks for Indian pharmaceutical companies following the proposed US executive order aimed at slashing drug prices by 30–80%. Both brokerages se...
Sun Pharma drops 5.45%, Lupin down 2.44% as pharma shares react to Trump’s drug price order
Pharmaceutical stocks came under pressure on Monday morning despite a broader market rally, following remarks by former U.S. President Donald Trump. At 9:24 AM, the Sensex was up 1,855.97 points at 81...
Nifty 50 top losers this week (May 10): Sun Pharmaceutical, Asian Paints, IndusInd Bank, Jio Financial Services and more
The Indian share markets wrapped up the week on a bearish note, with benchmark indices registering notable declines amid global uncertainty and domestic profit-booking. The BSE Sensex fell by 880.34 p...
Nifty 50 top losers today, May 7: Asian Paints, Sun Pharmaceutical, Bajaj Auto, ITC, Grasim Industries and more
Indian stock markets closed on a positive note on May 7, 2025, despite experiencing a volatile trading session. The Sensex saw a modest rise of 105.71 points, or 0.13%, closing at 80,746.78, while the...
Nifty 50 top losers today, April 29: Sun Pharma, UltraTech Cement, Coal India, ONGC and more
The Indian stock market experienced a volatile session on April 29, 2025, with benchmark indices ultimately closing on a flat note. The BSE Sensex gained 70.01 points, or 0.09%, to end the day at 80,2...
Nifty 50 top gainers today, April 28: Reliance Industries, Sun Pharma, JSW Steel, Bharat Electronics and more
Indian share market ended the day on a positive note with the Nifty 50 closing at a solid 24,328.50 on April 28. The Sensex surged by 1,005.84 points, closing at 80,218.37, while the Nifty gained 289....
Nifty 50 top gainers today, April 17: Eternal, Sun Pharmaceutical, ICICI Bank, Bharti Airtel and more
The Indian equity market witnessed a robust rally on April 17, 2025, with benchmark indices closing significantly higher. The Nifty 50 surged by 414.45 points or 1.77%, ending the session at 23,851.65...
Glenmark, Sun & Zydus recall products in US for 'manufacturing deviations'
India News: NEW DELHI: Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (.
Sun Pharma shares jump over 4% after US court clears LEQSELVI™ launch
Shares of Sun Pharmaceutical Industries Ltd. surged 4.29% to ₹1,723 in early trade on Friday after the company received a major legal win in the U.S. that removes barriers to the launch of its product...
Sun Pharma cleared to launch LEQSELVI™ in U.S. as court vacates injunction
Sun Pharmaceutical Industries has received a major legal boost in its U.S. operations after the U.S. Court of Appeals for the Federal Circuit ruled in its favor and vacated the preliminary injunction ...
Indian pharma stocks tumble as Trump signals tariffs on drug imports
Indian pharmaceutical stocks experienced a downturn following Donald Trump's renewed threat to impose tariffs on pharmaceutical imports. The Nifty Pharma index fell by 1.7%, with major companies like ...
Pharma Stocks Falls: Aurobindo Pharma slips 2%, Lupin down 2%, Divi’s Labs falls 3% as Trump reiterates tariffs on pharmaceuticals ‘soon’
Indian pharmaceutical stocks declined in early trade on Wednesday following renewed concerns over potential U.S. import tariffs. At 9:36 AM, Aurobindo Pharma shares were down 2% to ₹1,073.15, Dr. Redd...
Sun Pharma launches FEXUCLUE 40 mg in India for treatment of Erosive Esophagitis
Sun Pharmaceutical Industries Limited has announced the launch of FEXUCLUE® (Fexuprazan) 40 mg tablets in India, a novel treatment for Erosive Esophagitis. FEXUCLUE® is a Potassium-Competitive Acid Bl...
Sun Pharma shares fall over 4% today as tariff concerns resurface for pharma sector
Shares of Sun Pharmaceutical Industries Ltd fell 4.50% to ₹1,690.40 on Friday, declining ₹79.60 from the previous close of ₹1,770.00, after U.S. President Donald Trump announced that his administratio...
Nifty 50 top gainers today, April 3: Power Grid, Sun Pharmaceutical, Cipla, UltraTech and more
The Indian equity market witnessed a downturn on April 3, as both the Sensex and Nifty 50 closed in the red following the announcement of fresh U.S. tariffs. The benchmark Sensex dropped 322.08 points...
Sun Pharma shares rise over 5% as U.S. excludes Indian pharmaceutical exports from 26% tariff regime
Shares of Sun Pharmaceutical Industries Ltd surged 5.20% to ₹1,802.80 in early trade on April 3 after the White House confirmed that pharmaceutical products will not be subject to the 26% reciprocal t...
Sun Pharma, Dr. Reddy’s, Welspun India, Bharat Forge, Lupin, Biocon, UPL, Aurobindo, Indo Count, Cummins India and over 100 other Indian companies could face major impact from 26% US tariff hike
In a major escalation of trade tensions, US President Donald Trump on April 2 announced a 26% reciprocal tariff on imports from India, citing high tariffs imposed by India on American goods. The move ...
Pharma and healthcare stocks: Macquarie turns bullish on Sun Pharma, Cipla, Lupin; bearish on Apollo Hospitals, Max Healthcare
Macquarie believes the recent correction in pharmaceutical formulation stocks triggered by tariff-related concerns presents a compelling buying opportunity. In its latest sector note, the brokerage ha...
Nifty 50 top losers today, March 27: Tata Motors, Sun Pharmaceutical, Eicher Motors, Apollo Hospitals and more
The Indian equity markets continued their bullish momentum on March 27, with benchmark indices ending the trading session on a positive note. The Nifty 50 closed at 23,591.95, gaining 105.10 points (0...